What I can verify: the supplied OpenAlex excerpt lists high-impact biomedical publications by an Oswald Wagner author profile (e.g., articles in J. Biol. Chem., Cell Metabolism, Blood, NEJM, and JCO), suggesting substantial scientific productivity and influence.
Key skeptical caveat: βOswald Wagnerβ is an ambiguous name; bibliometric aggregation can mix distinct people. Without ORCID/affiliation disambiguation for each paper, author-level conclusions have uncertainty.
Long Explanation
Author Review: Oswald Wagner
Scope & method: I use (1) the provided OpenAlex excerpt (counts by year, topics, and top-works list) and (2) the provided top-work DOIs to assess what kinds of biological claims are supported by the literature. I do not assume that every βOswald Wagnerβ paper in the excerpt is the same individual unless the disambiguation is explicit.
Publication activity over time (from provided OpenAlex excerpt)
Raw βworks_countβ by year appears in the supplied excerpt; this is a descriptive plot only (bibliometrics can mix authors with the same name).
Citation accumulation proxy over time (from provided excerpt)
Provided excerpt includes βcited_by_countβ per year bucket; interpret cautiously because citation windows differ by publication age.
Provided βtop worksβ list: what kinds of biology they cover
These items are taken from the supplied OpenAlex excerpt. I summarize what the cited paper title/abstract indicates, and I flag limits: I have not read the full text hereβonly the metadata/abstract you provided.
Tumor angiogenesis; endothelial genetics in lymphoma
Topic lens (from provided OpenAlex excerpt)
The excerpt lists topic scores; treat as a soft classification (not a rigorous mapping of experiments to ontology).
Scientific strength signals I can support from the provided citations
1) Cell and translational mechanistic biology (example: endothelial secretion)
The provided top-work βPolar secretion of endothelin-1 by cultured endothelial cellsβ explicitly frames an experimental aim around directionality of endothelin-1 secretion in endothelial monolayers, i.e., mechanistic cell biology rather than purely observational inference.
2) Translational risk biomarkers for complex disease (example: cancer-associated VTE)
The VTE-related provided works indicate a repeated theme: predictive biomarkers (soluble P-selectin; D-dimer; prothrombin fragment 1+2) in cancer populations, consistent with quantitative clinical epidemiology / risk stratification research.
Critical skepticism: predictive-marker papers are susceptible to confounding, selection bias, and overfitting if the pipeline isnβt validated. I cannot assess those risks from the excerpt alone; full-text methods/validation are required.
3) Disease biology linking genetics, microenvironment, and cell state (example: lymphoma endothelium)
The NEJM-provided top work focuses on genetic aberrations in microvascular endothelial cells within B-cell lymphomas, positioning endothelial cells as tumor-related components of angiogenesis.
Critical note: studies claiming tumor-microenvironment genetic involvement often depend on cell-isolation specificity and inference about causality; without full methods, the rigor cannot be scored here.
The excerpt also lists: a review on HO-1 promoter polymorphisms in human disease, which suggests interest in gene regulation and oxidative-stress pathways;
and mechanistic experiments like βKisspeptin-10β¦ invasion inhibitor of primary human trophoblasts,β implying functional assays of invasion/inhibition;
plus a metabolism-linked macrophage polarization paper.
5) Scope mismatch risk: provided additional βER-stress/Alzheimerβsβ paper metadata is NOT linked to Wagner in your prompt
You provided full metadata for a very recent paper (DOI: 10.64898/2026.02.23.707382) about ER-stress signaling and Alzheimerβs proteins (APP/PSEN1) regulating ribosomal translation fidelity. However, your prompt does not state that this paper is authored by Oswald Wagnerβso I cannot attribute it to him without an explicit author list match.
What would most improve confidence (disconfirming evidence)
Author identity linkage: ORCID/affiliation disambiguation for each top-cited βOswald Wagnerβ paper (to prevent mixing).
Full-text methods audit: sample sizes, inclusion/exclusion, randomization/blinding (if any), cross-validation/holdout sets for biomarker work, and off-target assessment for perturbation experiments.
Replication & robustness: whether key claims were reproduced by independent groups and in different cohorts/species.
Highest-level skeptical conclusion: Based on the provided top-work DOIs, the research themes look plausibly mechanistic and clinically translational across multiple biomedical domainsβbut the current evidence quality assessment is limited by (a) excerpt-only information and (b) name-disambiguation uncertainty.
Knowledge graph (title-level themes only)
This diagram uses only what is evident from the provided titles/abstract snippets; it does not infer causal relationships.
Feedback:
Updated: March 22, 2026
BGPT Author Review
Scientific Quality
60%
Based on the provided OpenAlex excerpt and listed top works, the research themes appear scientifically substantive (cell biology, mechanistic signaling, genetics in disease, and quantitative biomarker studies). However, the evidence here is excerpt-level: name-disambiguation risk (βOswald Wagnerβ ambiguity), lack of full-text methodological audit, and inability to verify causal rigor/replication from metadata alone reduce confidence.
Communication Quality
50%
Communication quality canβt be verified from metadata. The presence of high-impact journals suggests competence, but without abstracts/full text for the specific authorβs writing contributions, the assessment is necessarily limited.
Author Novelty
60%
The listed works include a mix of mechanistic and translational topics; novelty is plausible but cannot be scored reliably without reading the original contributions and how they were later superseded or refined.
Scientific Rigor
50%
Some listed areas imply experimental rigor (e.g., cell signaling assays; genetic aberrations in microvascular cells; translation-related mechanistic framing), but rigor depends on methods, controls, and validation. The current evidence is insufficient for a strong rigor score.
It will retrieve each provided top-work DOI, build a citation/theme table, and compute a normalized βtheme diversity vs clinical-translational ratioβ from extracted titles/abstract cues.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
βAll cited biomarkers in cancer VTE are interchangeable surrogates of the same underlying pathology.β This is unlikely because coagulation/adhesion markers reflect partially distinct pathways and kinetics.
βAPP/PSEN1 effects on translation fidelity are identical across human and mouse.β This is falsified by systematic cross-species coupling differences and depends on human cell-type context.
Science Art
Science Movie
Make a narrated HD Science movie for this answer ($32 per minute)
Explore by Goal
Quick Explanation
Long Explanation
Top Data Sources
Ask a Follow-Up
Key Insight
Analysis 
Hypothesis Graveyard
Discussion